Elizabeth A. M. Feijen

Princess Máxima Center — Netherlands

Medicine · Health Sciences

23h-index2.2kcitations69works1.42yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Childhood Cancer Survivors' Quality of Life(52), Chemotherapy-induced cardiotoxicity and mitigation(37), Acute Lymphoblastic Leukemia research(27), Heart Failure Treatment and Management(9), Palliative Care and End-of-Life Issues(7)

Publications69 total

Supplemental Figure 2 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Table 4 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Table 3 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Figure 1 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Table 1 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Figure 3 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Supplemental Table 2 from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Data from Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
2025Open Access
Risk Factors for Valvulopathy Among Childhood Cancer Survivors
JAMA Oncology·2025· 3 citedOpen Access
Genetic Contribution to Treatment-Related Dyslipidemia in Adult Survivors of Childhood Cancer: Findings from the CCSS, SJLIFE, and DCCSS-LATER Cohorts
Cancer Epidemiology Biomarkers & Prevention·2025Open Access
IGHG Recommendations for Anthracycline and Anthraquinone Cardiac Dysfunction Equivalence Ratios After Childhood Cancer
JACC CardioOncology·2025· 2 citedOpen Access
A structured approach for data collection and visualization of the International Childhood Cancer Core Outcomes
EJC Paediatric Oncology·2025Open Access
Cyclophosphamide is not associated with clinically relevant late pulmonary dysfunction in Dutch survivors of childhood cancer – The DCCSS-LATER 2 PULM sub-study
Respiratory Medicine·2025· 2 citedOpen Access
Novel Potential Blood Biomarkers for Detection of Anthracycline-Related Cardiomyopathy in Childhood Cancer Survivors
JACC CardioOncology·2025Open Access
Treatments affecting splenic function as a risk factor for valvular heart disease in Childhood Cancer Survivors: A DCCSS‐LATER study
Pediatric Blood & Cancer·2024· 2 citedOpen Access
Unhealthy lifestyle behaviors, overweight, and obesity among childhood cancer survivors in the Netherlands: A DCCSS LATER study
Cancer·2024· 7 citedOpen Access
A Biomarker-Based Diagnostic Model for Cardiac Dysfunction in Childhood Cancer Survivors
JACC CardioOncology·2024· 9 citedOpen Access
Presence and utility of electrocardiographic abnormalities in long-term childhood cancer survivors
Heart·2024· 1 citedOpen Access
Secondary prevention of anthracycline cardiotoxicity in childhood cancer survivors
The Lancet Oncology·2024· 1 cited
The cumulative burden of self‐reported, clinically relevant outcomes in long‐term childhood cancer survivors and implications for survivorship care: A DCCSS LATER study
Cancer·2023· 10 citedOpen Access
page 1 of 4Next →

Frequent Co-authors

Leontien C.M. Kremer(43), Helena J. H. van der Pal(26), Cécile M. Ronckers(25), Jacqueline J. Loonen(22), Elvira C van Dalen(21), Wim J. E. Tissing(21), Annelies M. C. Mavinkurve‐Groothuis(16), Eline van Dulmen‐den Broeder(16), Jop C. Teepen(16), Wouter E.M. Kok(14), Margriet van der Heiden‐van der Loo(14), Jan M. Leerink(12), Dorine Bresters(12), Marry M. van den Heuvel‐Eibrink(12), Livia Kapusta(12), Roderick Skinner(11), Edit Bárdi(11), Esmée C. de Baat(11), Claudia E. Kuehni(11), Flora E. van Leeuwen(10)